Inhibrx Biosciences, Inc. (INBX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -38.03M | -30.12M | -33.82M | -29.95M | -35.9M | -43.72M | -30.28M | -57.36M | -63.05M | -56.82M | -54.24M | -42.3M | -39.94M | -30.6M | -30.84M | -26.92M | -26.94M | -22.62M | -13.68M | -22.38M |
| Operating CF Margin % | - | - | - | -2304.08% | - | -43720% | - | -57358% | - | -3477.42% | -45584.03% | -140996.67% | -234964.71% | -11167.88% | -11092.81% | -3786.5% | -2944.37% | -797.6% | -545.26% | -2437.91% |
| Operating CF Growth % | -5.94% | 31.1% | -11.7% | 47.78% | 43.07% | 23.06% | 44.18% | -35.6% | -57.85% | -85.69% | -75.9% | -57.12% | -48.26% | -35.28% | -125.51% | -20.29% | -24.45% | -46.99% | 1.49% | -97.9% |
| Net Income | -33.44M | -32.83M | -35.26M | -28.65M | -43.31M | -47.87M | -43.86M | 1.83B | -78.71M | -93.6M | -51.79M | -47.05M | -48.92M | -40.91M | -35.33M | -37.73M | -31.25M | -21.19M | -20.58M | -20.71M |
| Depreciation & Amortization | 537K | 564K | 583K | 661K | 675K | 689K | 760K | 475K | 360K | 298K | 304K | 295K | 295K | 302K | 309K | 307K | 307K | 307K | 299K | 298K |
| Stock-Based Compensation | 0 | 2.74M | 3.17M | 2.77M | 2.45M | 2.98M | 2.96M | 47.53M | 6.4M | 6.43M | 6.53M | 0 | 0 | 5.36M | 4.69M | 5.3M | 5.11M | 4.18M | 3.49M | 3.95M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9K |
| Other Non-Cash Items | 3.87M | 1.12M | 1.1M | 1.07M | 967K | 470K | 498K | -1.97B | 1.71M | 4.61M | 1.69M | 7.91M | 7.26M | 1.68M | 224K | 1.06M | 902K | -3.36M | 776K | 602K |
| Working Capital Changes | -8.99M | -1.72M | -3.42M | -5.8M | 3.32M | 4K | 9.36M | 35.49M | 7.2M | 25.45M | -10.97M | -3.45M | 1.42M | 2.98M | -737K | 4.14M | -2M | -2.56M | 2.34M | -6.51M |
| Change in Receivables | -9K | 660K | 130K | -753K | 206K | 707K | 260K | 1K | -610K | -447K | -4K | -23K | -47K | 58K | 0 | 134K | -4K | -129K | 97K | -181K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -58K | 0 | 0 | 0 | 0 | 408K | -1.28M |
| Change in Payables | 2.82M | -829K | -1.52M | -600K | -353K | -3.12M | -450K | 17.42M | 4.05M | 0 | -1.59M | -1.54M | 2.33M | 19K | 0 | 1.47M | -1.26M | 0 | 2.34M | -4.23M |
| Cash from Investing | 0 | 0 | -7K | 0 | -21K | -16K | -247K | -1.22M | -1.12M | -3.44M | -811K | -317K | -23K | -267K | 20K | -322K | -117K | -267K | -169K | -359K |
| Capital Expenditures | 0 | 0 | -10K | 0 | -21K | -16K | -247K | -1.22M | -1.12M | -3.44M | -811K | -317K | -23K | -267K | 20K | -322K | -117K | -267K | -169K | -414K |
| CapEx % of Revenue | - | - | - | - | - | 16% | - | 1215% | - | 210.65% | 681.51% | 1056.67% | 135.29% | 97.45% | 7.19% | 45.29% | 12.79% | 9.41% | 6.74% | 45.1% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 3K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55K |
| Cash from Financing | 75.46M | 1.25M | 352K | 0 | 99.84M | 0 | 0 | 32.95M | 38.73M | 860K | 199.89M | 854K | 356K | 158.66M | 506K | 60.16M | 39.22M | 41.48M | 820K | 40.48M |
| Debt Issued (Net) | 74.99M | 0 | 0 | 0 | 99.97M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 471K | 1.25M | 0 | 0 | 0 | -32.95M | 0 | 32.95M | 38.73M | 0 | 0 | 854K | 356K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 352K | 0 | -125K | 32.95M | 0 | 0 | 0 | 860K | 199.89M | 0 | 0 | 158.66M | 506K | 60.16M | 39.22M | 41.48M | 820K | 40.48M |
| Net Change in Cash | 37.44M | -28.87M | -33.48M | -29.95M | 63.92M | -43.74M | -30.53M | -25.62M | -25.44M | -59.4M | 144.84M | 0 | 0 | 127.79M | -30.31M | 32.92M | 12.17M | 18.6M | -13.02M | 17.74M |
| Free Cash Flow | -38.03M | -30.12M | -33.83M | -29.95M | -35.92M | -43.74M | -30.53M | -58.57M | -64.17M | -60.26M | -55.06M | -42.62M | -39.97M | -30.87M | -30.82M | -27.24M | -27.06M | -22.89M | -13.84M | -22.79M |
| FCF Margin % | - | - | - | -2304.08% | - | -43736% | - | -58573% | - | -3688.07% | -46265.55% | -142053.33% | -235100% | -11265.33% | -11085.61% | -3831.79% | -2957.16% | -807.02% | -551.99% | -2483.01% |
| FCF Growth % | -5.87% | 31.13% | -10.83% | 48.86% | 44.03% | 27.42% | 44.55% | -37.44% | -60.56% | -95.23% | -78.65% | -56.42% | -47.71% | -34.87% | -122.61% | -19.52% | -24.91% | -43.03% | 2.38% | -95.3% |
| FCF per Share | -2.44 | -1.94 | -2.19 | -1.94 | -2.32 | -3.02 | -1.97 | -3.96 | -1.18 | -1.12 | -1.17 | -0.98 | -0.92 | -0.71 | -0.79 | -0.70 | -0.69 | -0.59 | -0.37 | -0.60 |
| FCF Conversion (FCF/Net Income) | 1.14x | 0.92x | 0.96x | 1.05x | 0.83x | 0.91x | 0.69x | -0.03x | 0.80x | 0.61x | 1.05x | 0.90x | 0.82x | 0.75x | 0.76x | 0.71x | 0.80x | 1.07x | 0.66x | 1.08x |
| Interest Paid | 0 | 0 | 2.54M | 2.54M | 0 | 0 | 0 | 4.61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |